• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干细胞和祖细胞如何影响肾脏疾病。

How Stem and Progenitor Cells Can Affect Renal Diseases.

机构信息

Department of Interdisciplinary Medicine, University of Bari Aldo Moro, 70124 Bari, Italy.

Department of Precision and Regenerative Medicine and Ionian Area, University of Bari Aldo Moro, 70124 Bari, Italy.

出版信息

Cells. 2024 Aug 30;13(17):1460. doi: 10.3390/cells13171460.

DOI:10.3390/cells13171460
PMID:39273032
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11393889/
Abstract

Stem and progenitor cells have been observed to contribute to regenerative processes in acute renal failure and chronic kidney disease. Recent research has delved into the intricate mechanisms by which stem and progenitor cells exert their influence on kidney diseases. Understanding how these cells integrate with the existing renal architecture and their response to injury could pave the way for innovative treatment strategies aimed at promoting kidney repair and regeneration. Overall, the role of stem and progenitor cells in kidney diseases is multifaceted, with their ability to contribute to tissue regeneration, immune modulation, and the maintenance of renal homeostasis. Here, we review the studies that we have available today about the involvement of stem and progenitor cells both in regenerative therapies and in the causes of renal diseases, as well as in natural healing mechanisms, taking into account the main kidney disorders, such as IgA nephropathy, lupus nephritis, diabetic nephropathy, C3 glomerulopathy, focal segmental glomerulosclerosis, idiopathic membranous nephropathy, anti-glomerular basement membrane glomerulonephritis, and ANCA-associated crescentic glomerulonephritis. Moreover, based on the comprehensive data available in the framework of the specific kidney diseases on stem cells and renal progenitors, we hypothesize a possible role of adult renal progenitors in exacerbating or recovering the illness.

摘要

干细胞和祖细胞已被观察到在急性肾衰竭和慢性肾脏病的再生过程中发挥作用。最近的研究深入探讨了干细胞和祖细胞对肾脏疾病产生影响的复杂机制。了解这些细胞如何与现有肾脏结构整合以及它们对损伤的反应,可能为旨在促进肾脏修复和再生的创新治疗策略铺平道路。总的来说,干细胞和祖细胞在肾脏疾病中的作用是多方面的,它们能够促进组织再生、免疫调节和肾脏内稳态的维持。在这里,我们回顾了目前关于干细胞和祖细胞在再生疗法以及肾脏疾病的病因、自然愈合机制中的作用的研究,同时考虑了主要的肾脏疾病,如 IgA 肾病、狼疮性肾炎、糖尿病肾病、C3 肾小球病、局灶节段性肾小球硬化症、特发性膜性肾病、抗肾小球基底膜肾小球肾炎和 ANCA 相关的新月体性肾小球肾炎。此外,根据特定肾脏疾病中关于干细胞和肾祖细胞的综合数据,我们假设成人肾祖细胞可能在疾病的加重或恢复中发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1217/11393889/5c3c6bd0e4b5/cells-13-01460-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1217/11393889/5c3c6bd0e4b5/cells-13-01460-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1217/11393889/5c3c6bd0e4b5/cells-13-01460-g001.jpg

相似文献

1
How Stem and Progenitor Cells Can Affect Renal Diseases.干细胞和祖细胞如何影响肾脏疾病。
Cells. 2024 Aug 30;13(17):1460. doi: 10.3390/cells13171460.
2
[The incidence of renal diseases as diagnosed by biopsy in Hungary].[匈牙利经活检诊断的肾脏疾病发病率]
Orv Hetil. 2004 Jun 27;145(26):1373-9.
3
[Instructions and implementations for percutaneous renal biopsy. Guidelines for the therapy of glomerular nephropaties].[经皮肾活检的操作指南与实施。肾小球疾病治疗指南]
G Ital Nefrol. 2003 Sep-Oct;20 Suppl 24:S3-47.
4
Membranous nephropathy with crescents: a series of 19 cases.膜性肾病伴新月体:19 例系列。
Am J Kidney Dis. 2014 Jul;64(1):66-73. doi: 10.1053/j.ajkd.2014.02.018. Epub 2014 Apr 4.
5
Advances in Understanding of Pathogenesis and Treatment of Immune-Mediated Kidney Disease: A Review.免疫介导性肾病发病机制和治疗研究进展:综述
Am J Kidney Dis. 2022 Apr;79(4):582-600. doi: 10.1053/j.ajkd.2021.07.019. Epub 2021 Sep 8.
6
Disease recurrence in paediatric renal transplantation.小儿肾移植中的疾病复发
Pediatr Nephrol. 2009 Nov;24(11):2097-108. doi: 10.1007/s00467-009-1137-6. Epub 2009 Feb 27.
7
Acquired glomerular lesions in patients with Down syndrome.唐氏综合征患者获得性肾小球病变。
Hum Pathol. 2012 Jan;43(1):81-8. doi: 10.1016/j.humpath.2011.04.009. Epub 2011 Jul 5.
8
Non-neoplastic renal diseases in Kerala, India--analysis of 1592 cases, a two year retrospective study.印度喀拉拉邦的非肿瘤性肾脏疾病——1592例病例分析,一项为期两年的回顾性研究。
Indian J Pathol Microbiol. 2007 Apr;50(2):300-2.
9
A reevaluation of routine electron microscopy in the examination of native renal biopsies.对常规电子显微镜检查在天然肾活检中的重新评估。
J Am Soc Nephrol. 1997 Jan;8(1):70-6. doi: 10.1681/ASN.V8170.
10
Distribution of glomerular diseases in Taiwan: preliminary report of National Renal Biopsy Registry-publication on behalf of Taiwan Society of Nephrology.台湾地区肾小球疾病的分布:国家肾脏活检登记处初步报告——代表台湾肾脏病学会发表
BMC Nephrol. 2018 Jan 10;19(1):6. doi: 10.1186/s12882-017-0810-4.

引用本文的文献

1
Matrix Metalloproteinases in Ureteropelvic Junction Obstruction: Their Role in Pathogenesis and Their Use as Clinical Markers.输尿管肾盂连接处梗阻中的基质金属蛋白酶:它们在发病机制中的作用及其作为临床标志物的应用
Cells. 2025 Mar 31;14(7):520. doi: 10.3390/cells14070520.

本文引用的文献

1
Safety and Biodistribution of an Autologous Bone Marrow-Derived Mononuclear Cell Infusion into Renal Arteries in Patients with Focal Segmental Glomerulosclerosis: A Phase 1 Study.局灶节段性肾小球硬化患者肾动脉内自体骨髓来源单个核细胞输注的安全性和生物分布:一项1期研究。
Stem Cells Int. 2024 Jul 9;2024:2385568. doi: 10.1155/2024/2385568. eCollection 2024.
2
The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.补体在肾脏疾病中的作用:KDIGO(改善全球肾脏病预后组织)争议会议的结论。
Kidney Int. 2024 Sep;106(3):369-391. doi: 10.1016/j.kint.2024.05.015. Epub 2024 Jun 4.
3
Factor B Inhibition with Iptacopan in Recurrent C3 Glomerulopathy Following Kidney Transplant: A Report of Two Cases.
在肾移植后复发性C3肾小球病中使用依他库帕抑制补体B因子:两例报告
Kidney Med. 2024 Apr 12;6(6):100823. doi: 10.1016/j.xkme.2024.100823. eCollection 2024 Jun.
4
The complement system in the pathogenesis and progression of kidney diseases: What doesn't kill you makes you older.补体系统在肾脏病发病机制和进展中的作用:杀不死你的,让你更老。
Eur J Intern Med. 2024 Jun;124:22-31. doi: 10.1016/j.ejim.2024.02.015. Epub 2024 Mar 8.
5
Colony stimulating factor-1 receptor drives glomerular parietal epithelial cell activation in focal segmental glomerulosclerosis.集落刺激因子-1 受体驱动局灶节段性肾小球硬化症肾小球壁层上皮细胞的活化。
Kidney Int. 2024 Jul;106(1):67-84. doi: 10.1016/j.kint.2024.02.010. Epub 2024 Feb 28.
6
The therapeutic effect of mesenchymal stem cells in diabetic kidney disease.间充质干细胞在糖尿病肾病中的治疗效果。
J Mol Med (Berl). 2024 Apr;102(4):537-570. doi: 10.1007/s00109-024-02432-w. Epub 2024 Feb 29.
7
Recurrent C3 glomerulopathy after kidney transplantation.移植肾后复发性 C3 肾小球病。
Transplant Rev (Orlando). 2024 Apr;38(2):100839. doi: 10.1016/j.trre.2024.100839. Epub 2024 Feb 21.
8
Lupus Nephritis Biomarkers: A Critical Review.狼疮性肾炎生物标志物:批判性综述。
Int J Mol Sci. 2024 Jan 9;25(2):805. doi: 10.3390/ijms25020805.
9
Should we enlarge the indication for kidney biopsy in patients with diabetes? The pro part.我们是否应该扩大糖尿病患者肾活检的适应症?支持方观点。
Clin Kidney J. 2023 Oct 26;17(1):sfad266. doi: 10.1093/ckj/sfad266. eCollection 2024 Jan.
10
IgA nephropathy.IgA 肾病。
Nat Rev Dis Primers. 2023 Nov 30;9(1):67. doi: 10.1038/s41572-023-00476-9.